Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance
- PMID: 20852189
- PMCID: PMC2944574
- DOI: 10.1128/AAC.00422-10
Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance
Figures

Comment on
-
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2009 May;53(5):2100-9. doi: 10.1128/AAC.01197-08. Epub 2009 Feb 23. Antimicrob Agents Chemother. 2009. PMID: 19237648 Free PMC article.
-
Tuberculosis and trimethoprim-sulfamethoxazole.Antimicrob Agents Chemother. 2009 Nov;53(11):4789-93. doi: 10.1128/AAC.01658-08. Epub 2009 Jun 29. Antimicrob Agents Chemother. 2009. PMID: 19564358 Free PMC article.
-
Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates.Antimicrob Agents Chemother. 2009 Sep;53(9):4010-2. doi: 10.1128/AAC.00433-09. Epub 2009 Jul 6. Antimicrob Agents Chemother. 2009. PMID: 19581462 Free PMC article.
-
Reconsidering some approved antimicrobial agents for tuberculosis.Antimicrob Agents Chemother. 2009 Nov;53(11):4577-9. doi: 10.1128/AAC.00887-09. Epub 2009 Sep 8. Antimicrob Agents Chemother. 2009. PMID: 19738008 Free PMC article. No abstract available.
Similar articles
-
Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2010 Nov;54(11):4951-2; author reply 4952. doi: 10.1128/AAC.00876-10. Antimicrob Agents Chemother. 2010. PMID: 20947864 Free PMC article. No abstract available.
-
[Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].Zhonghua Jie He He Hu Xi Za Zhi. 2007 Sep;30(9):683-5. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 18070553 Chinese.
-
Coregulation of dihydrofolate reductase and thymidylate synthase B in bacillus subtilis.Biochim Biophys Acta. 1985 Feb 20;824(2):99-103. doi: 10.1016/0167-4781(85)90085-5. Biochim Biophys Acta. 1985. PMID: 3918568
-
Studies of Plasmodium falciparum dihydrofolate-reductase thymidylate synthase: potential advantages.Prog Clin Biol Res. 1989;313:29-43. Prog Clin Biol Res. 1989. PMID: 2675115 Review. No abstract available.
-
The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites.Pharmacol Ther. 1990;48(1):45-59. doi: 10.1016/0163-7258(90)90017-v. Pharmacol Ther. 1990. PMID: 2274577 Review.
Cited by
-
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.Clin Microbiol Rev. 2016 Apr;29(2):239-90. doi: 10.1128/CMR.00055-15. Clin Microbiol Rev. 2016. PMID: 26912567 Free PMC article. Review.
-
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.Antimicrob Agents Chemother. 2012 Dec;56(12):6080-7. doi: 10.1128/AAC.01641-12. Epub 2012 Sep 24. Antimicrob Agents Chemother. 2012. PMID: 23006760 Free PMC article. Review.
-
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.Ann Clin Microbiol Antimicrob. 2022 Nov 5;21(1):48. doi: 10.1186/s12941-022-00537-z. Ann Clin Microbiol Antimicrob. 2022. PMID: 36335391 Free PMC article.
References
-
- Argyrou, A., M. Vetting, B. Aladegbami, and J. Blanchard. 2006. Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid. Nat. Struct. Mol. Biol. 13:408-413. - PubMed
-
- Baca, A., R. Sirawaraporn, S. Turley, W. Sirawaraporn, and W. Hol. 2000. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. J. Mol. Biol. 302:1193-1212. - PubMed
-
- Besier, S., A. Ludwig, K. Ohlsen, V. Brade, and T. Wichelhaus. 2007. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int. J. Med. Microbiol. 297:217-225. - PubMed
-
- Besier, S., J. Zander, B. C. Kahl, P. Kraiczy, V. Brade, and T. A. Wichelhaus. 2008. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 52:2183-2189. - PMC - PubMed
-
- Chatterjee, I., A. Kriegeskorte, A. Fischer, S. Deiwick, N. Theimann, R. Proctor, G. Peters, M. Herrmann, and B. Kahl. 2008. In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J. Bacteriol. 190:834-842. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources